Építés alatt – nem éles oldal
Belépés
Csak meghívásosFázis nélkül

Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem

A legfontosabb adatok

Ki végzi
MicroPort Orthopedics Inc.
Hol
Englewood és Scottsdale (Egyesült Államok)Mind a 2 helyszín megnézése
Azonosító
Állapot
Csak meghívásos
Résztvevők
150 fő, tervezett
Kezdés
2020. okt. 21.
Várható befejezés
2033. nov. 1.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Total Hip Arthroplasty Implant
A regiszteradat frissítve
2024. március 20.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults who have had, or will have, a first total hip replacement (THA) using the PROFEMUR® Preserve Classic Stem with other WMT or MPO hip parts. It follows them for 10 years.

Életkor
21 years and older
Nem
All sexes
A betegség stádiuma
First (primary) hip replacement for non-inflammatory joint wear such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli or painful hip dysplasia. Also for inflammatory joint disease such as rheumatoid arthritis, or to correct a functional deformity.
Korábbi kezelés
People who already have the implant must join within 3 years of their first hip replacement. People who had a revision surgery after other treatments or devices failed cannot join.

A részvétel fő kizáró okai

  • Hip parts from makers other than MPO or WMT
  • Infection at the time of implant, in the hip or elsewhere in the body
  • Hepatitis or HIV infection, now or in the past
  • Nerve, muscle or bone problems that affect walking or weight-bearing, or neuropathic joints
  • Documented substance abuse, or being in prison now or soon

A regiszter feltételei, szó szerint

Mind a 21 feltétel megnézéseKevesebb

Ki vehet részt

  • Has previously undergone or currently has determined to undergo primary THA with the specified combination of components: PROFEMUR® Preserve Classic Stem combined with other Wright Medical Technologies (WMT) or MPO THA components including acetabular shells, acetabular liners and femoral heads
  • Has previously undergone or currently has been determined to undergo a primary THA for any of the following:
  • non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia
  • inflammatory degenerative joint disease such as rheumatoid arthritis
  • correction of functional deformity 3. Willing and able to complete required study visits and assessments through the 10 year postoperative follow-up visit 4. Previously implanted subjects must be enrolled within 3 years of their primary THA implantation

Ki nem vehet részt

  • Has or had inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable
  • Has or had an overt infection at the time of implantation
  • Has or had a distant foci of infections (which may cause hematogenous spread to the implant site) at the time of implantation
  • Has or had a rapid disease progression as manifested by joint destruction or bone absorption apparent on roentgenogram at the time of implantation
  • Has or had hepatitis or HIV infection
  • Has or had a neurological or musculoskeletal disease that may adversely affect gait or weight-bearing
  • Has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study
  • Has a medical condition, as judged by the investigator, that would interfere with the subject's ability to comply with the requirements of the protocol -
  • Skeletally immature (less than 21 years of age) at time of implantation
  • Implanted with non-MPO or non-WMT components (femoral heads, acetabular shells, acetabular liners)
  • Has or had neuropathic joints
  • Has had a revision procedure(s) where other treatments or devices have failed; and treatment of fractures that are unmanageable using other techniques
  • Currently enrolled in another clinical investigation which could affect the endpoints of this protocol
  • Unwilling or unable to sign the Informed Consent document
  • Has documented substance abuse issue
  • Currently incarcerated or has impending incarceration

Helyszínek itt: Egyesült Államok

  • HCA Research Institute, OrthoONE at Swedish Medical CenterEnglewood, Egyesült ÁllamokCsak meghívásos
  • HonorHealth Research InstituteScottsdale, Egyesült ÁllamokCsak meghívásos

A vizsgálatról

Mit akar kideríteni a vizsgálat

Sponsor is conducting this post market clinical study to evaluate the safety and effectiveness of its PROFEMUR® Preserve Classic Femoral Stem. This type of study is required by regulatory authorities for all devices that have been approved in Europe (EU) to evaluate the medium and long-term clinical evidence. This study has been designed in accordance with MEDDEV2.12/2 (European Medical Device Vigilance System) rev2 and ISO (International Organization of Standardization) 14155:2011 guidelines.

A vizsgált kezelések

  • Total Hip Arthroplasty Implant

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2024. március 20.